Bosh sahifaABT • NYSE
add
Abbott Laboratories
Yopilish kursi
132,69 $
Kunlik diapazon
127,88 $ - 131,48 $
Yillik diapazon
110,86 $ - 141,23 $
Bozor kapitalizatsiyasi
225,09 mlrd USD
Oʻrtacha hajm
5,66 mln
Narx/foyda
16,15
Dividend daromadliligi
1,82%
Asosiy maydon
NYSE
Yangiliklarda
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (USD) | iyn, 2025info | Y/Y qiyosi |
|---|---|---|
Daromad | 11,14 mlrd | 7,37% |
Joriy xarajat | 4,09 mlrd | 3,13% |
Sof foyda | 1,78 mlrd | 36,64% |
Sof foyda marjasi | 15,97 | 27,25% |
Har bir ulushga tushum | 1,26 | 10,53% |
EBITDA | 2,98 mlrd | 13,85% |
Amaldagi soliq stavkasi | 17,26% | — |
Balans
Jami aktivlari
Jami passivlari
| (USD) | iyn, 2025info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 7,28 mlrd | 0,87% |
Jami aktivlari | 84,00 mlrd | 15,04% |
Jami passivlari | 33,17 mlrd | -0,86% |
Umumiy kapital | 50,83 mlrd | — |
Tarqatilgan aksiyalar | 1,74 mlrd | — |
Narxi/balansdagi bahosi | 4,57 | — |
Aktivlardan daromad | 6,64% | — |
Kapitaldan daromad | 8,68% | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
| (USD) | iyn, 2025info | Y/Y qiyosi |
|---|---|---|
Sof foyda | 1,78 mlrd | 36,64% |
Operatsiyalardan naqd pul | 2,05 mlrd | 4,44% |
Sarmoyadan naqd pul | -582,00 mln | -28,48% |
Moliyadan naqd pul | -1,10 mlrd | -38,69% |
Naqd pulning sof oʻzgarishi | 419,00 mln | -40,40% |
Boʻsh pul | 1,27 mlrd | -10,95% |
Haqida
Abbott Laboratories is an American multinational medical devices and health care company with headquarters in Abbott Park, Illinois. The company produces pharmaceuticals for sale outside the United States, diagnostic products, nutritional products, and medical devices.
Abbott operates in over 160 countries and sources from at least 62 suppliers worldwide.
Abbott's products include Pedialyte, Similac, BinaxNOW, Ensure, Glucerna, ZonePerfect, FreeStyle Libre, i-STAT and MitraClip.
The company is ranked 107th on the Fortune 500 and 144th on the Forbes Global 2000. Wikipedia
Tashkil etilgan
1888
Sayt
Xodimlar soni
114 000
